Current trends in perioperative treatment of resectable gastric cancer

doi:10.4240/wjgs.v15.i3.323

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3167)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

258

WORD

HTML

2196

Figures (1-1)

149

Tables (1-2)

215

Sum=2850

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

106

Download

211

Sum=317

Mar 27, 2023 (publication date) through Jul 6, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Surg. Mar 27, 2023; 15(3): 323-337
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.323

Full Size Figure Download Figure

Figure 1 Perioperative algorithm for resectable gastric cancer. ¹Strongly recommended for diffuse type gastric cancer. ²Upfront surgery may be recommended. ³Radiotherapy for R1/2 resection. CT: Computed tomography; PET-CT: Positron emission tomography computed tomography; EUS: Endoscopic ultrasound; FLOT: Fluorouracil, leucovorin, oxaliplatin, docetaxel; MSI: Microsatellite instability; HER2: Human epidermal growth factor 2; ICI: Immune checkpoint inhibitor; MSI-H: High microsatellite instability; MSS: Microsatellite stability; PD-L1: Programmed death-ligand 1.

Citation: Yıldız İ, Özer L, Şenocak Taşçı E, Bayoglu İV, Aytac E. Current trends in perioperative treatment of resectable gastric cancer. World J Gastrointest Surg 2023; 15(3): 323-337
URL: https://www.wjgnet.com/1948-9366/full/v15/i3/323.htm
DOI: https://dx.doi.org/10.4240/wjgs.v15.i3.323